CYTOKYN M / INTERLEUKIN1MOD
Next-generation, anti-inflammatory, recombinant cytokines paving the way to a new therapeutic for a longer human healthspan.
Achievements
Team
Prototype
Users
Partners
Revenue
Investors
What we offer
Dynamic, academic research lead start-up, lead product candidate, strong (pre-)clinical development partner, IP protection, current negotiations with leading biotech VC, late contender in XPRIZE Healthspan competition, embedded in tech/biotech start-up ecosystem.
Target group
50+
Challenges
- XPRIZE Healthspan Semifinals
- Pre-clinical/clinical testing
- Regulatory steps
